Ahmed R, Sawatari H, Deshpande S, et al. - Presence of atrial fibrillation (AF) in patients receiving surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) was shown to cause a significant increase in length of stay and adjusted healthcare adjusted costs but did not independently elevate the in-hospital mortality.

• Experts assessed if AF presence during TAVI or SAVR alters the length of stay, healthcare adjusted costs, and inpatient mortality.

• Median length of stay increased by 33.3% in AF patients vs those without AF undergoing TAVI and SAVR.

• Due to AF, there was an increment in the median value of adjusted healthcare associated expenses of both TAVI ($46,754 vs $49,960) and SAVR ($40,948 vs $45,683).

• AF did not independently raise the in-hospital mortality.